Apple has taken a major leap in accessibility innovation with the introduction of a brain-computer interface (BCI) protocol integrated into its Switch Control feature. Announced on Tuesday, this protocol enables iOS, iPadOS, and visionOS devices to support direct interaction via neural signals—letting users control devices without physical input or voice commands.

One of the first adopters is New York-based neurotechnology firm Synchron. The company confirmed that its implantable BCI, the Stentrode, will soon allow users to operate iPhones, iPads, and Apple Vision Pro devices using only their thoughts. “This is a pivotal moment for both accessibility and neurotechnology,” Synchron stated. The integration with Apple’s native accessibility tools, such as Switch Control, promises a seamless and intuitive user experience.

Synchron’s CEO and Co-Founder, Tom Oxley, called the move transformative. “BCI isn’t just about accessibility—it’s the future of human-computer interaction,” he said. “Apple’s support elevates brain input to the same level as touch, voice, and typing. That opens new possibilities for people with paralysis and beyond.”

A Game-Changer for the BCI Industry

Tetiana Aleksandrova, CEO of biotechnology firm Subsense, described Apple’s move as a breakthrough. “This is Apple throwing the doors wide open to clinically validated BCI systems,” she said. Aleksandrova emphasized that it signals mainstream readiness for neural input technologies. “For patients, it means direct ‘mind-to-message’ control—no middleware required. For the industry, it’s a green light from one of tech’s biggest players.”

She noted Apple’s pattern of building revolutionary features through its accessibility pipeline. “Apple often starts by solving edge-case challenges, refining the user experience to perfection, and eventually mainstreaming the solution,” she explained. “That’s how we got Siri from VoiceOver, and now BCI could follow the same path.”

Aleksandrova believes BCI fits naturally into Apple’s mission of expanding access. “For users with conditions like ALS or traumatic brain injury, BCI technology could restore digital agency—using only brain activity.”

Analysts Urge Patience

While the announcement is widely hailed as groundbreaking, analysts suggest its broader impact is still years away. Will Kerwin, a tech equity analyst at Morningstar, noted, “It’s an exciting development, but it’s still early days for full-scale commercialization.”

He highlighted that Synchron’s BCI technology has only been tested on 10 individuals so far and that U.S. FDA approval could be years off. “Long-term, this could reshape human-device interaction, especially as AI continues to evolve. But for now, it’s more of a glimpse into the future than a market-ready tool.”

Minimally Invasive, Scalable, and Safe

Unlike traditional BCIs, Synchron’s Stentrode is implanted through blood vessels, not open-brain surgery—dramatically reducing risk and making it more accessible for patients. “Scalability has always been a challenge in this field,” explained Synchron spokesperson Kimberly Ha. “Our approach bypasses the need for invasive brain surgery, which positions us for broader clinical use.”

BCI application development also faces technical hurdles. Aleksandrova noted that systems must balance high signal fidelity with patient safety. “Surgical implants give great signal, but they’re invasive. Non-invasive approaches are safer, but less accurate,” she said.

Subsense is exploring nanoparticle-based BCIs that can pass through the blood-brain barrier to interact with neurons, offering a non-surgical alternative with two-way communication.

Expanding the BCI Horizon

Beyond medical use, experts believe BCI could transform digital experiences—enabling hands-free navigation, adaptive gaming, and immersive XR environments. “This opens the door for applications in communication, cognitive enhancement, and mental health,” said Aleksandrova.

Apple’s embrace of BCI technology doesn’t just redefine accessibility—it signals a new era where thought-driven computing could become part of everyday life.

Source